Leishmaniasis, Cutaneous

Also known as: Cutaneous leishmaniasis

DrugDrug NameDrug Description
DB09031MiltefosineAn antileishmanial agent used to treat leishmaniasis, a group of disease caused by parasites of the Leishmania type.
DrugDrug NamePhaseStatusCount
DB13732Meglumine antimoniate0Completed1
DB01421Paromomycin0Completed1
DB06723Aluminum hydroxide1Completed1
DB00681Amphotericin B1 / 2Completed1
DB13110Antimony2Completed3
DB13110Antimony2Terminated1
DB00798Gentamicin2Completed2
DB00798Gentamicin2Terminated3
DB00724Imiquimod2Completed1
DB13732Meglumine antimoniate2Completed2
DB09031Miltefosine2Completed5
DB09031Miltefosine2Terminated1
DB01421Paromomycin2Completed3
DB01421Paromomycin2Terminated3
DB00738Pentamidine2Completed2
DB13047Pentavalent Antimony2Completed2
DB00020Sargramostim2Completed1
DB05630Sodium stibogluconate2Completed2
DB13110Antimony2 / 3Completed1
DB00207Azithromycin2 / 3Terminated1
DB13732Meglumine antimoniate2 / 3Completed2
DB13732Meglumine antimoniate2 / 3Terminated1
DB01421Paromomycin2 / 3Completed1
DB00738Pentamidine2 / 3Completed1
DB00806Pentoxifylline2 / 3Completed2
DB00196Fluconazole3Terminated1
DB00798Gentamicin3Completed1
DB00724Imiquimod3Completed1
DB13732Meglumine antimoniate3Completed1
DB13732Meglumine antimoniate3Terminated2
DB13732Meglumine antimoniate3Unknown Status1
DB09031Miltefosine3Completed1
DB09031Miltefosine3Not Yet Recruiting1
DB09031Miltefosine3Unknown Status1
DB00435Nitric Oxide3Terminated1
DB01421Paromomycin3Completed2
DB05386Regramostim3Not Yet Recruiting1
DB13732Meglumine antimoniate4Completed1
DB09031Miltefosine4Completed1
DB05630Sodium stibogluconate4Completed1
DB00437AllopurinolNot AvailableCompleted1
DB13110AntimonyNot AvailableCompleted1
DB13732Meglumine antimoniateNot AvailableCompleted1
DB01421ParomomycinNot AvailableAvailable1
DB05630Sodium stibogluconateNot AvailableAvailable1
DB05630Sodium stibogluconateNot AvailableUnknown Status1